The cosmetics industry generates over $500 billion annually. The vast majority of that spending funds formulations whose efficacy has never been evaluated in a randomized clinical trial. Terms like "dermatologically tested," "clinically proven," or "patented active" carry no regulatory weight. They decorate packaging without constraining content. Amid this noise, the relevant question is straightforward: which molecules actually have data published in peer-reviewed journals?
The answer fits in a few lines. That is precisely what makes it useful.
Photoaging vs chronoaging: understanding what actually damages skin
Skin ages through two distinct mechanisms. Chronoaging (intrinsic aging) is genetically programmed. It is slow, relatively uniform, and manifests as a progressive thinning of the dermis. It cannot be prevented.
Photoaging is a different matter. Ultraviolet radiation (UVA and UVB) directly degrades collagen and elastin fibers in the dermis. It generates reactive oxygen species (unstable molecules that attack cellular components) and damages DNA. This triggers a chronic inflammatory cascade. UVA, which accounts for 95% of UV radiation reaching the earth's surface, penetrates into the deep dermis and passes through clouds and glass alike.
Ultraviolet radiation is responsible for 80% of visible signs of skin aging: wrinkles, hyperpigmentation, loss of firmness.
A 4-year randomized trial published in the Annals of Internal Medicine demonstrated that daily application of SPF 30+ sunscreen reduces visible skin aging by 24% compared to occasional use (PubMed). This is the simplest, least expensive, and best-documented intervention available. Before investing in a 150-euro serum, apply sunscreen every morning.
A detail many overlook: UVA passes through standard glass. Professional drivers exhibit significantly more pronounced skin aging on the window-exposed side. UV-blocking films on office or vehicle windows block up to 99% of this radiation while allowing visible light through.
Documented topical actives
A handful of molecules have solid clinical data for daily skincare.
Topical Vitamin C. L-ascorbic acid at 10-20% is an antioxidant whose photoprotective and anti-pigmentary efficacy has been confirmed in multiple clinical trials (PubMed). It also contributes to collagen synthesis. Formulation matters: vitamin C is unstable and oxidizes rapidly. Look for acidic pH formulations (< 3.5) in opaque containers. Alternative: Magnesium Ascorbyl Phosphate (MAP) is a stabilized, non-acidic form, less potent as an antioxidant but compatible with more actives (notably GHK-Cu).
Niacinamide. This form of vitamin B3, used at 4-5% topically, improves barrier function, reduces redness, and attenuates hyperpigmentation. Its tolerance profile is excellent, making it compatible with most skin types (PubMed).
Topical Vitamin E. Tocopherol (the active form of vitamin E) is a lipid-soluble antioxidant that protects cell membranes against UV-induced lipid peroxidation. Applied topically, vitamin E reduces photochemical damage, attenuates erythema, and supports wound healing (PubMed). Its efficacy is synergistic with vitamin C: the two together provide photoprotection superior to either active used alone.
Topical Hyaluronic Acid. Hyaluronic acid is a glycosaminoglycan naturally present in the dermis, capable of retaining up to 1,000 times its weight in water. In topical application, only low molecular weight formulas (< 300 kDa) penetrate the skin. Too high a weight (> 1,000 kDa) stays on the surface and can paradoxically dehydrate by drawing water from deeper layers to the surface (PubMed). Look for serums that explicitly indicate low molecular weight.
Ceramides. These lipids naturally constitute 50% of the skin barrier. Topical formulations containing ceramides restore this barrier when compromised, particularly after retinoid exposure or in cases of chronic dryness (PubMed).
Tretinoin: the gold standard of retinoids
Tretinoin (all-trans retinoic acid) is the most extensively studied topical retinoid for skin aging. It is a prescription medication, 10 to 20 times more potent than over-the-counter retinol. The difference is not marketing. It is molecular: retinol must be converted to retinoic acid by the body before it can act, with variable efficiency across individuals.
A systematic review of 7 randomized clinical trials showed significant and lasting improvement in wrinkles, texture, and pigmentation from 4 months of use onward (PubMed). The mechanism is well characterized: tretinoin accelerates the renewal of surface skin cells, stimulates collagen production in the dermis, and slows degradation of the extracellular matrix (the fiber network that gives skin its structure and firmness).
For those who prefer to avoid a prescription, retinol (0.3 to 1%) is an accessible alternative. Its efficacy is lower but remains documented, provided stabilized formulations are used and the regimen is maintained for several months.
GHK-Cu: the copper peptide that outperforms retinol on certain parameters
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a tripeptide naturally present in human plasma. Its plasma concentration is approximately 200 µg/L at age 20, then declines with age (PubMed). This decline correlates directly with diminished skin regeneration capacity.
The biological mechanisms are well documented. GHK-Cu stimulates the synthesis of collagen, elastin, and glycosaminoglycans (the molecules that maintain dermal hydration). It promotes vascular growth and supports fibroblast activity (PubMed).
The clinical data are more compelling than one might expect from such an under-publicized peptide. In a 12-week trial, GHK-Cu improved collagen production in 70% of treated women, compared to 50% for vitamin C and 40% for retinoic acid (PubMed). In another study, a GHK-Cu serum in lipid nanovectors applied twice daily for 8 weeks reduced wrinkle volume by 55.8% and wrinkle depth by 32.8% versus the control serum (PubMed).
After 8 weeks of twice-daily GHK-Cu application in lipid nanovectors, compared to control serum.
The main challenge is skin penetration. GHK-Cu is a hydrophilic compound, while the stratum corneum (the outermost skin layer) is lipophilic. A portion of the peptide applied to the surface remains blocked and never reaches the deeper layers. Liposomal formulations improve this absorption. The clinical results cited above were obtained with simple topical application, meaning partial penetration is sufficient to produce measurable effects.
Compatibility
GHK-Cu fits into a daily routine with a few simple rules.
GHK-Cu + L-ascorbic vitamin C: incompatible simultaneously. The acidity (pH < 3.5) destabilizes the copper complex. Solution: separate them (vitamin C in the morning, GHK-Cu in the evening), or use Magnesium Ascorbyl Phosphate (MAP), a stable, non-acidic form compatible with GHK-Cu in simultaneous application.
GHK-Cu + niacinamide: documented synergy. Niacinamide strengthens the skin barrier and reduces inflammation. Both can be applied together.
GHK-Cu + tretinoin: compatible. Both target complementary pathways (regeneration vs renewal). Sequential application (GHK-Cu in the morning, tretinoin in the evening) avoids any interaction and simplifies the protocol.
Spilanthol: the natural myorelaxant
Spilanthol is an alkamide extracted from Acmella oleracea (paracress), a plant used for centuries in traditional medicine. Its mechanism is distinct from all previous actives: it acts as a local myorelaxant by blocking voltage-gated sodium channels in subcutaneous muscle fibers. The result is a progressive inhibition of the muscle contractions responsible for expression lines — a mechanism analogous to botulinum toxin, but topical and reversible.
Spilanthol's triple mechanism makes it particularly compelling. Beyond myorelaxation, it inhibits the COX and LOX pathways (anti-inflammatory) and stimulates collagen synthesis. Clinical data show approximately 15% wrinkle reduction within 2 weeks, hydration improvement of 10 to 40%, and skin roughness reduction of 20 to 30% (PubMed).
An underappreciated advantage: spilanthol is an excellent skin penetration enhancer (4 to 6x factor for other actives applied simultaneously). Its small molecular size (221 Da) and lipophilicity (LogP 3.39) give it remarkable transcutaneous penetration. This means it potentiates the absorption of GHK-Cu, niacinamide, and vitamin C when applied together in the morning.
Compatibility and timing
Spilanthol + GHK-Cu, niacinamide, vitamin C (MAP): synergy. Spilanthol enhances the penetration of these actives and their mechanisms are complementary (myorelaxation + regeneration + antioxidant + barrier).
Spilanthol + tretinoin or AHA: separate. Spilanthol potentiates the penetration of tretinoin and acids, increasing the risk of irritation. Apply in the morning (spilanthol) and evening (tretinoin) to avoid this interaction.
Commercial concentrations: 0.05 to 1% in cosmetic formulations. Serums based on Acmella oleracea extract are the most common form.
Microneedling: the penetration accelerator
Microneedling (dermaroller or dermapen) creates micro-channels in the stratum corneum, allowing topical actives to reach the deeper dermal layers. For GHK-Cu, the gain is considerable: a study on human skin showed that microneedle pretreatment increases peptide penetration by a factor of 20, from near-zero to 134 nanomoles over 9 hours, with no observed irritation (PubMed).
Microneedling is never daily. The skin needs time to heal between sessions. Clinical protocols recommend one session per month with 0.25 to 0.5 mm needles (sufficient to breach the stratum corneum without causing significant bleeding), then spacing to one session every 2 to 3 months for maintenance.
On session day, apply GHK-Cu serum immediately after microneedling. It is the only active recommended at that point: as a precaution, stop tretinoin and acidic vitamin C (L-ascorbic) 24 hours before and reintroduce them 24 hours after. Niacinamide and hyaluronic acid are compatible from the next day.
This is a periodic accelerator, not a prerequisite. The clinical results for GHK-Cu were obtained with simple topical application. Microneedling amplifies them.
Beyond topicals: nutrition and supplementation for skin
The skin renews itself entirely in approximately 28 days. This renewal depends on available building materials: amino acids, essential fatty acids, vitamins, minerals. Diet is therefore the foundation.
A diet rich in omega-3 fatty acids, vitamin E, and carotenoids is associated with better UV damage protection in observational studies (PubMed). Adequate sleep is another underrated lever: epidermal regeneration intensifies during deep sleep phases.
Regarding oral supplementation, two compounds have solid clinical data.
Collagen peptides. At doses exceeding 10g per day, hydrolyzed collagen peptides improve skin hydration and elasticity in randomized, placebo-controlled trials (PubMed). The proposed mechanism: absorbed peptides stimulate fibroblasts (the dermal cells responsible for manufacturing collagen) to produce more of it.
Oral hyaluronic acid. Unlike topical use (where only low molecular weight formulas penetrate the skin), oral hyaluronic acid is effective across varied molecule sizes (300 to 800 kDa, a unit of molecular weight). A dose of 120mg per day for 12 weeks significantly improves skin hydration (PubMed).
The evidence-based daily protocol
Everything above condenses into a concrete routine. The goal is adherence: a protocol abandoned after three weeks is worthless, regardless of the evidence behind each active.
Morning
- Gentle cleanser (pH 5-5.5)
- Spilanthol serum (Acmella oleracea) — myorelaxant + penetration enhancer for the following actives
- Vitamin C (MAP for direct compatibility with GHK-Cu, or L-ascorbic if applied without GHK-Cu) + vitamin E (photoprotective synergy)
- GHK-Cu serum + hyaluronic acid (low molecular weight)
- Niacinamide 4-5%
- Moisturizer (ceramides)
- Broad-spectrum SPF 30+ sunscreen
Evening
- Gentle cleanser
- Hyaluronic acid (low molecular weight)
- Niacinamide 4-5% (reduces tretinoin irritation, stimulates ceramide production)
- Tretinoin (0.025% to start, every other evening, gradual increase)
- Occlusive moisturizer (ceramides + vitamin E)
Monthly microneedling
One session per month (0.25-0.5 mm), followed immediately by GHK-Cu serum. As a precaution, stop tretinoin and L-ascorbic acid 24 hours before and reintroduce them 24 hours after. Space to one session every 2 to 3 months for maintenance.
For specific product recommendations matching each active in this protocol, see the Skin Care section of our Infrastructure page.
Advanced interventions (fractional laser 1927nm or 1550nm, focused ultrasound) fall within professional dermatology. They deliver measurable results on texture, pigmentation, and firmness, but require a qualified practitioner and do not replace the daily protocol. They complement it.
Frequently asked questions
References
- Hughes MCB et al. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790 (PubMed).
- Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. J Clin Aesthet Dermatol. 2017;10(7):14-17 (PubMed).
- Boo YC. Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants. 2021;10(8):1315 (PubMed).
- Ferreira MS et al. Tretinoin for photoaging: a systematic review. Skin Health Dis. 2022;2(2):e116 (PubMed).
- Pickart L et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108 (PubMed).
- Gruber R et al. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application. Pharmaceutics. 2023;15(10):2500 (PubMed).
- Zhang S et al. Microneedle-Mediated Delivery of Copper Peptide Through Skin. Pharm Res. 2015;32(8):2678-2689 (PubMed).
- de Miranda RB et al. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461 (PubMed).
- Hsu TF et al. Oral hyaluronan relieves wrinkles and improves dry skin: a 12-week double-blinded, placebo-controlled study. Nutrients. 2021;13(7):2220 (PubMed).
- Keen MA, Hassan I. Vitamin E in dermatology. Indian Dermatol Online J. 2016;7(4):311-315 (PubMed).
- Pavicic T et al. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. J Drugs Dermatol. 2011;10(9):990-1000 (PubMed).
- Savic S et al. 'All-natural' anti-wrinkle emulsion serum with Acmella oleracea extract: A design of experiments (DoE) formulation approach, rheology and in vivo skin performance/efficacy evaluation. Int J Cosmet Sci. 2021;43(3):326-339 (PubMed).



